NCT04864951

HPV Prevalence in Transpersons - a Prospective Study

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 203 (actual)
• Sponsor: Sophie Pils · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

In this study, Human Papilloma Virus (HPV) prevalence will be determined once in the urine of 200 trans people. In addition, subjects will be asked to complete a questionnaire about their sexual orientation, which is adapted from the largest published study.

Detailed description

All transpeople who visit the outpatient clinic are asked to participate in the study. After being informed and signing the Informed Consent Form, the subjects are asked to give first-void urine and fill out the survey. The urine samples are sent pseudonymously to the University of Ljubljana for analysis. The subjects will be informed about their results within 3 weeks.If the result is positive, the subjects will be offered voluntary further care in our HPV outpatient clinic. However, this will take place outside the study. The data collected there can be used for further analyses.

Conditions

• Papillomavirus Infection
• Transsexualism

Interventions

Type	Name	Description
DIAGNOSTIC_TEST	Colli-Pee urine collection device	first-void urine is collected using Colli-Pee and subsequently analyzed using Anyplex™ II HPV HR Detection from Seegene.
OTHER	Survey	Subjects are asked to complete a survey that includes questions about sexual orientation, hormone therapy, gender reassignment surgery, number of sexual partners, HPV vaccination, and smoking

Timeline

• Start date: 2021-05-02
• Primary completion: 2021-11-01
• Completion: 2021-11-01
• First posted: 2021-04-29
• Last updated: 2023-03-15

Locations

2 sites across 2 countries: Austria, Slovenia